Andrea Necchi Selected Research

Penile Neoplasms (Penile Cancer)

5/2022	Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
1/2022	Second line salvage systemic therapy for advanced penile cancer.
12/2021	Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma.
10/2021	Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma.
10/2021	Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
1/2021	Salvage therapy for localized recurrences of penile cancer.
10/2020	Understanding genomics and the immune environment of penile cancer to improve therapy.
8/2020	Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer.
7/2020	Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.
1/2020	Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Necchi Research Topics

Disease

92	Neoplasms (Cancer) 10/2022 - 08/2009
87	Carcinoma (Carcinomatosis) 10/2022 - 10/2012
59	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 08/2015
34	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2013
24	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2021 - 01/2010
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 11/2009
16	Penile Neoplasms (Penile Cancer) 05/2022 - 01/2015
15	Disease Progression 10/2022 - 02/2015
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2015
7	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 01/2020
7	Seminoma 10/2021 - 06/2016
6	Non-Muscle Invasive Bladder Neoplasms 05/2022 - 01/2018
5	Microsatellite Instability 12/2021 - 01/2019
4	Urologic Neoplasms (Urological Cancer) 04/2022 - 10/2019
4	Lymphatic Metastasis 01/2021 - 01/2015
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 12/2018
3	Pathologic Complete Response 01/2021 - 01/2019
3	Testicular Neoplasms (Testicular Cancer) 01/2020 - 10/2011
3	Adenocarcinoma 01/2020 - 04/2011
3	Nonseminomatous germ cell tumor 11/2019 - 10/2016
2	Carcinoma in Situ 09/2022 - 01/2017
2	Pneumonia (Pneumonitis) 12/2020 - 05/2016
2	Neutropenia 12/2020 - 01/2020
2	Pain (Aches) 11/2020 - 11/2015
2	Lymphadenopathy 01/2020 - 01/2020
2	Residual Neoplasm 12/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

36	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 11/2010
35	PlatinumIBA 01/2022 - 08/2012
26	Immune Checkpoint InhibitorsIBA 04/2022 - 05/2016
23	pembrolizumabIBA 03/2022 - 09/2016
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2016
8	atezolizumabIBA 03/2022 - 05/2016
7	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
6	B7-H1 AntigenIBA 01/2022 - 01/2017
6	erdafitinibIBA 01/2022 - 01/2019
6	Monoclonal AntibodiesIBA 01/2022 - 09/2016
6	Biological ProductsIBA 12/2021 - 11/2009
6	NivolumabIBA 12/2020 - 09/2016
5	RamucirumabIBA 01/2022 - 11/2017
5	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
5	Etoposide (VP 16)FDA LinkGeneric 10/2021 - 06/2016
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 02/2019
5	AlbuminsIBA 01/2018 - 05/2014
5	Gemcitabine FDA Link 01/2018 - 02/2014
5	taxaneIBA 01/2017 - 01/2016
4	Pharmaceutical PreparationsIBA 10/2022 - 08/2012
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2015
4	Docetaxel (Taxotere)FDA Link 11/2020 - 01/2017
3	Carboplatin (JM8)FDA LinkGeneric 06/2022 - 01/2017
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2021
3	enfortumab vedotinIBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 11/2015
3	Tumor Biomarkers (Tumor Markers)IBA 06/2021 - 11/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 06/2016
3	durvalumabIBA 12/2020 - 01/2019
3	tremelimumabIBA 12/2020 - 01/2019
3	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2020 - 02/2016
3	LigandsIBA 01/2018 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 06/2014
3	Taxoids (Taxanes)IBA 04/2016 - 06/2015
3	pazopanib FDA Link 02/2016 - 08/2012
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2021
2	CreatinineIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2015
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2017
2	cyclopropapyrroloindoleIBA 11/2019 - 01/2018
2	Therapeutic UsesIBA 10/2019 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 11/2015
2	AntibodiesIBA 01/2018 - 01/2018
2	Aurora Kinase AIBA 01/2017 - 04/2016
2	MLN 8237IBA 01/2017 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 12/2016 - 01/2016
2	Brentuximab VedotinIBA 09/2016 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015 - 06/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 08/2015 - 06/2014

Therapy/Procedure

95	Drug Therapy (Chemotherapy) 06/2022 - 08/2009
65	Therapeutics 09/2022 - 08/2011
38	Immunotherapy 05/2022 - 09/2016
37	Cystectomy 09/2022 - 08/2015
30	Neoadjuvant Therapy 10/2022 - 08/2015
25	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 10/2011
19	Adjuvant Chemotherapy 06/2022 - 01/2015
10	Nephroureterectomy 10/2022 - 01/2017
10	Salvage Therapy 01/2021 - 06/2011
4	Radiotherapy 05/2022 - 12/2012
4	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 04/2016
4	Orchiectomy (Orchidectomy) 06/2021 - 12/2012
3	Transplantation 01/2018 - 03/2016
2	Adjuvant Radiotherapy 11/2022 - 01/2018
2	Operative Surgical Procedures 01/2022 - 10/2021
2	Castration 01/2022 - 10/2021
2	Nephrectomy 12/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2021 - 01/2017
1	Conservative Treatment 09/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022